Top compounds associated with response to C4A


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.0063 0.9
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0044 0.9
mRNA TG-100-115 CTRPv2 pan-cancer AAC 0.0051 0.9
mRNA pac-1 CTRPv2 pan-cancer AAC 0.0049 0.9
mRNA BRD1835 CTRPv2 pan-cancer AAC 0.0052 0.9
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.011 0.9
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.0048 0.9
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0043 0.9
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.007 0.9
mRNA ZSTK474 CTRPv2 pan-cancer AAC -0.0049 0.9
Download CSV